Results 1 to 10 of about 16,473 (168)

粪便中肿瘤M2型丙酮酸激酶联合潜血试验检测结直肠癌的效率分析 [PDF]

open access: yesZhongshan Daxue xuebao. Yixue kexue ban, 2006
【目的】探讨粪便中肿瘤M2型丙酮酸激酶(tumor M2-PK)联合潜血试验检测结直肠癌的临床意义。【方法】43例结直肠癌病人和43例健康正常人的粪便标本各1份,应用酶联免疫吸附测定法(ELISA)检测标本的tumor M2-PK水平,同时行免疫法粪便潜血试验(IFOBT)检测,比较二者单独及联合筛查结直肠癌的效率。【结果】粪便中tumor M2-PK水平中位值(最大值,最小值):结直肠癌组为8.6(0,59.0)U/mL,健康对照组为0.6(0,9.0)U/mL,两组差异有显著性意义(U=319,P ...
蔡观福   +4 more
doaj   +2 more sources

HARQ scheme for sparse code multiple access based on network coding [PDF]

open access: yes, 2022
To fulfill the stringent reliability and throughput demand of the beyond-5G and the forthcoming 6G, a novel network coding (NC) based hybrid automatic retransmission request (HARQ) for low-density parity check (LDPC) coded SCMA was proposed.Two ...
Jing LEI, Ke LAI, Lei WEN, Wei LIU
core   +1 more source

The value of combined detection of LDHA and PD-L1 in predicting the efficacy and prognosis of advanced gastric cancer patients treated with PD-1 inhibitor [PDF]

open access: yes, 2023
Background and purpose: The response rate of gastric cancer patients to programmed death-1 (PD-1) inhibitor is relatively low. Establishing a useful efficacy prediction method to screen the superior gastric cancer patients receiving anti-PD-1 therapy ...
ZUO Xueliang, CHEN Zhiqiang, DONG Runyu, WANG Zhixiong, CAI Juan
core   +1 more source

Test and Significance of CEA, NSE, CA125, CYFRA21-1 in Lung Cancer [PDF]

open access: yes, 2017
目的 探讨CEA、NSE、CA125、CYFRA21-1在肺癌中的检测及意义.方法 回顾性分析2015年10月—2016年12月医院收治的肺部疾病患者166例,其中89例肺癌患者设为肺癌组,其余77例肺部良性病变患者设为肺部良性病变组.另选择35名健康志愿者作为健康对照组,电化学发光法检测3组血清中CEA、NSE、CA125、CYFRA21-1含量,分析单项及联合检测对肺癌的诊断价值.结果 肺癌组患者血清CEA、NSE、CA125、CYFRA21-1分别为(4.32±0.83)ng/mL、(11.54 ...
何佳瑜, 何正, 罗世翊, 魏玲
core   +1 more source

Clinical value of alpha-fetoprotein: alpha-fetoprotein-L3 isoform ratio and des-γ-carboxyprothrombin in early diagnosis of HBV-related hepatocellular carcinoma [PDF]

open access: yes, 2023
Objective To evaluate the value of different combinations of alpha-fetoprotein (AFP), alpha-fetoprotein-L3 isoform ratio (AFP-L3%) and des-γ-carboxyprothrombin (DCP) for early diagnosis of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC ...
Duan Jianping, Du Lei, Song Ting, Liu Zhensheng
core   +1 more source

混样核酸检测联合酶免法筛查献血者乙肝病毒感染的残余风险分析

open access: yesZhongguo shiyan zhenduanxue, 2021
目的了解无偿献血者血液筛查中血液标本的输血传播乙型肝炎病毒(HBV)残余风险,评估应用混样核酸检验联合酶免法在降低输血传播乙肝病毒残余风险的作用。方法选取2016年1月-2019年12月焦作市中心血站无偿献血者182 525人,所有献血者献血前均已同意献血且献血者末梢血体检合格。分别用酶免法和混样核酸检验法(8人/份)筛查献血者HBV,并对混样核酸检验有反应的样本进行拆分单测,对核酸检测阳性献血者追踪检测。结果 2016年1月-2019年12月混样核酸检验联合酶免法共检测出1 493份不合格样本 ...
秦强国, 张国平, 李瑞丽
doaj  

Massive unsourced multiple access scheme based on block sequence codebook and compressed sensing [PDF]

open access: yes, 2023
A massive unsourced multiple access scheme based on block sequence codebook and compressed sensing was proposed for sporadic burst scenario in massive machine type communication (mMTC).Firstly, a large-capacity spreading codebook generation scheme was ...
Chulong LIANG   +3 more
core   +1 more source

肝素结合蛋白,降钙素原,中性粒细胞载脂蛋白联合检测对重症急性胰腺炎患者继发感染的评估作用

open access: yesZhongguo shiyan zhenduanxue, 2020
目的探讨肝素结合蛋白(HBP)、降钙素原(PCT)和中性粒细胞载脂蛋白(HNL)联合检测对重症急性胰腺炎(SAP)继发感染的评估价值。方法筛选SAP患者82例分为炎症组45例和非炎症组37例,检测两组患者血清的HBP、PCT和HNL水平,并比较这3种指标单独检测与联合检测诊断SAP继发感染的特异性、敏感性、阳性预测值、阴性预测值和符合率。结果炎症组患者血清HBP、PCT和HNL水平均显著高于非炎症组 ...
赵海鹏   +3 more
doaj  

Diagnotic Value of the Combined Determination of Telomerase Activity in Induced Sputum, Pleural Effusion and Fiberobronchoscopic Biopsy Samples in Lung Cancer [PDF]

open access: yes, 2010
Background and objective It has been proven that telomerase activation correlates with the carcinogenesis, aggressiveness and turnover of lung cancer.
Cheng ZHAO   +4 more
core  

Clinical research on progress of antinuclear antibody in rheumatoid arthritis [PDF]

open access: yes, 2023
Rheumatoid arthritis (RA) is a common chronic, systemic autoimmune disease characterized by erosive arthritis, with a global prevalence of 0.25% to 1.00%, which may ultimately lead to joint deformity and loss of function.
LI Yuan, ZHANG Le, YIN Hanlin, ZHENG Bing, LÜ Liangjing
core   +1 more source

Home - About - Disclaimer - Privacy